Found 280 matching trials
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia PHASE1 This phase I trial studies the side effects and best dose of AR-42 when giv...
Show More Location
Cincinnati Children's Hospital
Learn More & Join Trial
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) PHASE2 The goal of this clinical research study is to compare how 2 different drug...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia PHASE1 This phase I trial is studying the side effects and best dose of decitabine...
Show More Location
Princess Margaret Hospital Phase 2 Consortium
Learn More & Join Trial
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia PHASE1 Background:
Acute myeloid leukemia (AML) is a cancer of the white blood ce...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome PHASE1 The purpose of this study is to determine the pharmacokinetics (PK) of deci...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases PHASE1 This phase I trial is studying the side effects and best dose of vorinostat...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML PHASE2 The primary objectives of this study are to assess: (1) whether the combina...
Show More Location
UCLA Medical Center
Learn More & Join Trial
Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 PHASE1 STUDY BACKGROUND AND PURPOSE:
Acute myelogenous leukemia (AML) is a common...
Show More Location
Winship Cancer Institute of Emory University
Learn More & Join Trial
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial PHASE4 This study aims to determine whether the recurrence rate of high-risk acute...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML PHASE2 This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Show More Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Learn More & Join Trial